GPC3 and metastatic carcinoma: Glypican-3 (GPC3) is an oncofetal heparan sulfate proteoglycan that is currently used as a diagnostic biomarker for distinguishing HCC from normal liver tissue, benign hepatic tumors, and other types of metastatic carcinomas [18, 19].